#Gohibic (#vilobelimab) has been authorized for the treatment of #COVID19 in hospitalized adults within 48 hours of receiving ECMO or invasive mechanical ventilation.
Announcement here https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-gohibic-vilobelimab-injection-treatment-covid-19
#FDA #EUA #COVID #gohibic #vilobelimab #COVID19